Chronic Th2-skewed inflammation in atopic dermatitis, characterized by sustained IL-4, IL-13, and IL-6 signaling, can disrupt the BBB, promote microglial activation, and induce neuroinflammatory cascades that impair Aβ clearance. This evidence concerns the gene IL13 and atopic eczema.